药明康德(02359) - 营收构成

最后更新于:2024-06-30

数据选项
选择时间范围:
起始时间
结束时间
项目名称 (元) 2024-06 中报2023-12 年报2023-06 中报2022-12 年报2022-06 中报2021-12 年报
数额同比数额同比数额同比数额同比数额同比数额同比
按產品類型分
WuXiChemistry收入122.10亿-9.34%291.71亿1.12%134.67亿3.80%288.50亿104.79%129.74亿140.87亿
成本69.66亿-7.86%163.77亿-6.13%75.61亿-4.32%174.45亿103.82%79.02亿85.59亿
毛利率42.95%43.86%43.86%39.53%39.10%39.24%
WuXiTesting收入30.18亿-2.35%65.40亿14.36%30.91亿18.65%57.19亿26.38%26.05亿45.25亿
成本19.65亿-0.35%41.10亿10.05%19.72亿13.76%37.35亿20.57%17.34亿30.98亿
毛利率34.88%37.15%36.19%34.69%33.44%31.55%
WuXiBiology收入11.69亿-5.17%25.53亿3.13%12.33亿13.02%24.75亿24.69%10.91亿19.85亿
成本7.48亿-0.16%15.26亿0.45%7.50亿11.21%15.19亿24.91%6.74亿12.16亿
毛利率35.97%40.22%39.19%38.62%38.20%38.73%
WuxiATU收入5.75亿-19.43%13.10亿0.12%7.14亿15.96%13.08亿27.44%6.15亿10.26亿
成本7.47亿-3.11%14.67亿3.76%7.71亿14.61%14.14亿34.97%6.73亿10.48亿
毛利率-30.00%-12.03%-8.11%-8.11%-9.38%-2.08%
WuxiDDSU收入2.57亿-24.80%7.26亿-25.08%3.42亿-24.85%9.70亿-22.49%4.55亿12.51亿
成本1.07亿-56.49%4.68亿-34.68%2.46亿-27.39%7.17亿2.15%3.39亿7.02亿
毛利率58.37%35.54%28.04%26.06%25.53%43.90%
其他業務收入1,165.40万-53.07%4,104.80万22.11%2,483.30万55.61%3,361.50万22.15%1,595.80万2,752.00万
成本561.10万-63.65%2,005.90万12.01%1,543.40万98.99%1,790.80万24.15%775.60万1,442.40万
毛利率51.85%51.13%37.85%46.73%51.40%47.59%
按地區分
中國收入33.98亿5.31%73.72亿-2.05%32.27亿1.65%75.26亿29.71%31.75亿58.02亿
美國收入107.12亿-13.44%261.32亿0.96%123.75亿3.91%258.84亿113.10%119.09亿121.46亿
歐洲收入22.17亿-0.38%46.98亿6.00%22.25亿20.04%44.32亿19.16%18.53亿37.19亿
世界其他地區收入9.14亿-12.49%21.39亿41.46%10.45亿27.54%15.12亿626.65%8.19亿2.08亿
亞洲—其他收入10.26亿
合計收入172.41亿-8.64%403.41亿2.51%188.71亿6.28%393.55亿71.84%177.56亿229.02亿
成本105.40亿-6.85%239.68亿-3.54%113.16亿-0.12%248.48亿69.76%113.29亿146.37亿
毛利率38.87%40.59%40.04%36.86%36.19%36.09%